ESSA Pharma Inc. (EPIX)

USD 1.61

(-1.83%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue - - - - - -
Cost of Revenue 118.49 Thousand 121.78 Thousand 109.46 Thousand 110.32 Thousand - 34.48 Thousand
Gross Profit -118.49 Thousand -121.78 Thousand -109.46 Thousand -110.32 Thousand - -34.48 Thousand
Operating Expenses 32.13 Million 36.96 Million 37.14 Million 23.52 Million 12.16 Million 10.8 Million
Selling, General and Administrative Expenses 10.81 Million 12.54 Million 12.77 Million 11.37 Million 5.47 Million 5.92 Million
Research and Development Expenses 21.32 Million 24.41 Million 24.25 Million 12.14 Million 6.69 Million 4.87 Million
Other Expenses - 1.73 Million 109.46 Thousand 515 Thousand 35 Thousand -40 Thousand
Cost and Expenses 32.13 Million 36.96 Million 37.14 Million 23.52 Million 12.16 Million 10.8 Million
Operating Income -32.13 Million -35.34 Million -36.9 Million -23.11 Million -12.15 Million -10.8 Million
Interest Expense 6942.00 14 Thousand 22.22 Thousand 618 Thousand 603 Thousand 912 Thousand
Income Tax Expense 1600.00 -112 Thousand -34.34 Thousand -289 Thousand 38 Thousand 27 Thousand
Earnings before Tax -26.58 Million -35.21 Million -36.83 Million -23.73 Million -10.4 Million -11.6 Million
Net Income -26.58 Million -35.1 Million -36.8 Million -23.44 Million -10.44 Million -11.63 Million
Earnings Per Share Basic -0.60 -0.80 -0.96 -1.04 -1.24 -2.55
Earnings Per Share Diluted -0.60 -0.80 -0.96 -1.04 -1.24 -2.55
Weighted Average Shares Outstanding 44.08 Million 44.03 Million 38.48 Million 22.44 Million 8.43 Million 4.56 Million
Weighted Average Shares Outstanding (Diluted) 44.08 Million 44.03 Million 38.48 Million 22.44 Million 8.43 Million 4.56 Million
Gross Margin - - - - - -
EBIT Margin - - - - - -
Profit Margin - - - - - -
EBITDA -26.45 Million -35.07 Million -36.7 Million -23 Million -12.13 Million -10.76 Million
Earnings Before Tax Margin - - - - - -

Income Statement Charts